1 unchanged sentence
following exhibits are filed herewith or are incorporated by reference to exhibits previously filed with the SEC.
−Removed: Amended Settlement Allocation Agreement dated March 31,2022 between the Company and Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, Biofrontera Development GmbH, Biofrontera Neuroscience GmbH, (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed with the SEC on April 5, 2022).
+Added: Form of Common Stock Purchase Warrant issued in connection with the private placement on May 17, 2022 (the “May 2022 PIPE”) (incorporated by reference to Exhibit 4.1 to the Company’s Form 8-K filed with the SEC on May 20, 2022).
+Added: Form of Pre-Funded Common Stock Purchase Warrant issued in connection with the May 2022 PIPE (incorporated by reference to Exhibit 4.2 to the Company’s Form 8-K filed with the SEC on May 20, 2022).
+Added: to Employment Agreement effective as of April 1, 2022 – Erica Monaco (incorporated by reference to Exhibit 10.1 to the Company’s
+Added: Form 8-K filed with the SEC on April 5, 2022).
+Added: of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed with the SEC on
+Added: May 20, 2022).
+Added: Form of Registration Rights Agreement for May 2022 PIPE (incorporated by reference to Exhibit 10.2 to the Company’s Form 8-K filed with the SEC on May 20, 2022).
Certification
2 unchanged sentences
of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes Oxley Act of 2002
−Removed: Inline XBRL Instance Document
−Removed: Inline XBRL Taxonomy Extension
−Removed: Schema Document
−Removed: Inline XBRL Taxonomy Extension
−Removed: Calculation Linkbase Document
−Removed: Inline XBRL Taxonomy Extension
−Removed: Definition Linkbase Document
−Removed: Inline XBRL Taxonomy Extension
−Removed: Label Linkbase Document
−Removed: Inline XBRL Taxonomy Extension
−Removed: Presentation Linkbase Document
−Removed: Cover Page Interactive
−Removed: Data File (embedded within the Inline XBRL document and included in Exhibit 101)
−Removed: Filed herewith.
+Added: XBRL Instance Document
+Added: XBRL Taxonomy Extension Schema Document
+Added: XBRL Taxonomy Extension Calculation Linkbase Document
+Added: XBRL Taxonomy Extension Definition Linkbase Document
+Added: XBRL Taxonomy Extension Label Linkbase Document
+Added: XBRL Taxonomy Extension Presentation Linkbase Document
+Added: Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)
+Added: a management contract or compensatory plan or arrangement.
+Added: The schedules
+Added: (and similar attachments) to this exhibit have been omitted from this filing pursuant to Item 601(b)(10) of Regulation S-K.
+Added: The registrant
+Added: agrees to furnish a supplemental copy of any omitted schedule (or similar attachment) to the SEC upon request.
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.
−Removed: BIOFRONTERA INC.
+Added: August 12, 2022
Executive Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.